Bone Marrow Culture Yield for the Diagnosis of Opportunistic Diseases in Patients with AIDS and Disseminated Kaposi Sarcoma

Author(s): P. Cornejo-Juárez, B. Islas-Muñoz, A.F. Ramírez-Ibargüen, G. Rosales-Pedraza, B. Chávez-Mazari, A. Martínez-Orozco, P. Volkow-Fernández*

Journal Name: Current HIV Research
HIV and Viral Immune Diseases

Volume 18 , Issue 4 , 2020


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Background: Disseminated Kaposi sarcoma (DKS) is present in patients with advanced HIV infection in whom co-infection with other opportunistic pathogens can occur. Bone marrow (BM) aspirate and biopsy comprise a robust diagnostic tool in patients with fever, cytopenias, and abnormal liver tests. However, the yield in patients with DKS has not been determined.

Objective: The aim of this study was to evaluate the utility of BM aspirate and biopsy in patients with DKS.

Methods: We included 40 male patients with a recent diagnosis of DKS. BM aspirate and biopsy was performed as part of the workup to rule out co-infections.

Results: In four patients, Mycobacterium avium complex (MAC) was recovered from culture. In other four patients, intracellular yeasts were observed in the Grocott stain, diagnosed as Histoplasma. The yield of BM was calculated in 20%. Only 12 patients (30%) had fever and 11 (27.5%) had pancytopenia. Alkaline phosphatase (ALP) above normal values and C-reactive protein (CRP) were higher in patients with positive results for BM than in those with negative results (63% vs. 21.9%, and 3.0 vs. 1.2 mg/L; p = 0.03 in both comparisons). No differences were found when complete blood-count abnormalities were compared.

Conclusion: We recommend performing a BM aspirate for stains, culture, and biopsy in all HIV patients with DKS, as this will permit the early diagnosis of co-infections and prevent further complications in those who receive chemotherapy.

Keywords: Bone marrow culture, Kaposi sarcoma, utility, opportunistic diseases, HIV, AIDS.

[1]
No author cited. Morbidity and Mortality Weekly Report 1981; 305-8.
[2]
Gottlieb GJ, Ragaz A, Vogel JV, et al. A preliminary communication on extensively disseminated Kaposi’s sarcoma in young homosexual men. Am J Dermatopathol 1981; 3(2): 111-4.
[http://dx.doi.org/10.1097/00000372-198100320-00002] [PMID: 7270808]
[3]
Hymes KB, Cheung T, Greene JB, et al. Kaposi’s sarcoma in homosexual men-a report of eight cases. Lancet 1981; 2(8247): 598-600.
[http://dx.doi.org/10.1016/S0140-6736(81)92740-9] [PMID: 6116083]
[4]
Friedman-Kien AE, Laubenstein LJ, Rubinstein P, et al. Disseminated Kaposi’s sarcoma in homosexual men. Ann Intern Med 1982; 96(6 Pt 1): 693-700.
[http://dx.doi.org/10.7326/0003-4819-96-6-693] [PMID: 6283973]
[5]
Hansen RS. AhLoy RD, Meyer RD. The acquired immunodeficiency syndrome. Emerg Med Clin North Am 1985; 3(1): 3-23.
[PMID: 3902454]
[6]
Urmacher C, Myskowski P, Ochoa M Jr, Kris M, Safai B. Outbreak of Kaposi’s sarcoma with cytomegalovirus infection in young homosexual men. Am J Med 1982; 72(4): 569-75.
[http://dx.doi.org/10.1016/0002-9343(82)90450-8] [PMID: 6280498]
[7]
Tanaka PY, Hadad DJ, Barletti SC, de Souza SA, Calore EE. Bone marrow biopsy in the diagnoses of infectious and non-infectious causes in patients with advanced HIV infection. J Infect 2007; 54(4): 362-6.
[http://dx.doi.org/10.1016/j.jinf.2006.06.007] [PMID: 16875738]
[8]
Bolduc P, Roder N, Colgate E, Cheeseman SH. Care of Patients With HIV Infection: Medical Complications and Comorbidities. FP Essent 2016; 443: 16-22.
[PMID: 27092563]
[9]
Morris AK, Valley AW. Overview of the management of AIDS-related Kaposi’s sarcoma. Ann Pharmacother 1996; 30(10): 1150-63.
[http://dx.doi.org/10.1177/106002809603001015] [PMID: 8893123]
[10]
Ensoli B, Nakamura S, Salahuddin SZ, et al. AIDS-Kaposi’s sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 1989; 243(4888): 223-6.
[http://dx.doi.org/10.1126/science.2643161] [PMID: 2643161]
[11]
Locati M, Murphy PM. Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS. Annu Rev Med 1999; 50: 425-40.
[http://dx.doi.org/10.1146/annurev.med.50.1.425] [PMID: 10073287]
[12]
Chang Y. KSHV, Kaposi’s Sarcoma, and related lymphoproliferative disorders.. In Parsonnet J Microbes and Malignancy Infection as a cause of human cancers. Oxford University Press New York, USA 1999; pp. 207-31.
[13]
Gonçalves PH, Uldrick TS, Yarchoan R. HIV-associated Kaposi sarcoma and related diseases. AIDS 2017; 31(14): 1903-16.
[http://dx.doi.org/10.1097/QAD.0000000000001567] [PMID: 28609402]
[14]
Fiorelli V, Gendelman R, Samaniego F, Markham PD, Ensoli B. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi’s sarcoma spindle cells. J Clin Invest 1995; 95(4): 1723-34.
[http://dx.doi.org/10.1172/JCI117849] [PMID: 7535796]
[15]
van Schalkwyk WA, Opie J, Novitzky N. The diagnostic utility of bone marrow biopsies performed for the investigation of fever and/or cytopenias in HIV-infected adults at Groote Schuur Hospital, Western Cape, South Africa. Int J Lab Hematol 2011; 33(3): 258-66.
[http://dx.doi.org/10.1111/j.1751-553X.2010.01280.x] [PMID: 21118385]
[16]
Pande A, Bhattacharyya M, Pain S, Ghosh A, Samanta A. Diagnostic yield of bone marrow examination in HIV associated FUO in ART naïve patients. J Infect Public Health 2010; 3(3): 124-9.
[http://dx.doi.org/10.1016/j.jiph.2010.07.006] [PMID: 20869673]
[17]
Tripathi AK, Misra R, Kalra P, Gupta N, Ahmad R. Bone marrow abnormalities in HIV disease. J Assoc Physicians India 2005; 53: 705-10.
[PMID: 16398081]
[18]
Morais JC, Machado M, Biasoli I, Barroso PF, Milito C, Spector N. Changing patterns of AIDS: impact on the indications and diagnostic yield of bone marrow biopsies. Braz J Infect Dis 2010; 14(4): 419-21.
[http://dx.doi.org/10.1016/S1413-8670(10)70086-6] [PMID: 20963331]
[19]
Mwanda OW. Haematological changes in human immunodeficiency virus infection. Part I: Review article. East Afr Med J 1997; 74(11): 732-6.
[PMID: 9557449]
[20]
Duggan MJ, Weisenburger DD, Sun NC, Purtilo DT. Bone marrow findings in immunodeficiency syndromes. Hematol Oncol Clin North Am 1988; 2(4): 637-56.
[http://dx.doi.org/10.1016/S0889-8588(18)30589-6] [PMID: 3065323]
[21]
Llewelyn MJ, Noursedeghi M, Dogan A, Edwards SG, Miller RF. Diagnostic utility of bone marrow sampling in HIV-infected patients since the advent of highly active antiretroviral therapy. Int J STD AIDS 2005; 16(10): 686-90.
[http://dx.doi.org/10.1258/095646205774357343] [PMID: 16212717]
[22]
Gandapur AS, Nadeem S, Riaz M. Modood-ul-Mannan. Modood-ul-Mannan. Diagnostic importance of bone marrow examination in haematological malignant and non-malignant disorders. J Ayub Med Coll Abbottabad 2015; 27(3): 692-4.
[PMID: 26721042]
[23]
Khandekar MM, Deshmukh SD, Holla V, et al. Profile of bone marrow examination in HIV/AIDS patients to detect opportunistic infections, especially tuberculosis. Indian J Pathol Microbiol 2005; 48(1): 7-12.
[PMID: 16758774]
[24]
Labrador J, Pérez-López E, Martín A, Cabrero M, Puig N, Díez-Campelo M. Diagnostic utility of bone marrow examination for the assessment of patients with fever of unknown origin: a 10-year single-centre experience. Intern Med J 2014; 44(6): 610-2.
[http://dx.doi.org/10.1111/imj.12443] [PMID: 24946818]
[25]
Quesada AE, Tholpady A, Wanger A, Nguyen AND, Chen L. Utility of bone marrow examination for workup of fever of unknown origin in patients with HIV/AIDS. J Clin Pathol 2015; 68(3): 241-5.
[http://dx.doi.org/10.1136/jclinpath-2014-202715] [PMID: 25589792]
[26]
Hafner R, Inderlied CB, Peterson DM, et al. Correlation of quantitative bone marrow and blood cultures in AIDS patients with disseminated Mycobacterium avium complex infection. J Infect Dis 1999; 180(2): 438-47.
[http://dx.doi.org/10.1086/314865] [PMID: 10395860]
[27]
Miralles P, Moreno S, Pérez-Tascón M, Cosín J, Díaz MD, Bouza E. Fever of uncertain origin in patients infected with the human immunodeficiency virus. Clin Infect Dis 1995; 20(4): 872-5.
[http://dx.doi.org/10.1093/clinids/20.4.872] [PMID: 7795088]
[28]
Ker CC, Hung CC, Huang SY, et al. Comparison of bone marrow studies with blood culture for etiological diagnosis of disseminated mycobacterial and fungal infection in patients with acquired immunodeficiency syndrome. J Microbiol Immunol Infect 2002; 35(2): 89-93.
[PMID: 12099341]
[29]
Mir N, Costello C, Luckit J, Lindley R. HIV-disease and bone marrow changes: a study of 60 cases. Eur J Haematol 1989; 42(4): 339-43.
[http://dx.doi.org/10.1111/j.1600-0609.1989.tb01222.x] [PMID: 2721658]
[30]
Kilby JM, Marques MB, Jaye DL, Tabereaux PB, Reddy VB, Waites KB. The yield of bone marrow biopsy and culture compared with blood culture in the evaluation of HIV-infected patients for mycobacterial and fungal infections. Am J Med 1998; 104(2): 123-8.
[http://dx.doi.org/10.1016/S0002-9343(97)00353-7] [PMID: 9528729]
[31]
Keiser P, Rademacher S, Smith JW. Utility of bone marrow culture and biopsy in the diagnosis of disseminated infections in AIDS. Am J Hematol 1997; 56(1): 1-4.
[http://dx.doi.org/10.1002/(SICI)1096-8652(199709)56:1<1:AID-AJH1>3.0.CO;2-U] [PMID: 9298859]
[32]
World Health Organization. Global Health Observatory data repositoryIncidence data by WHO region Number of incident tuberculosis cases Updated 07 Oct 2017 Accessed 10 Nov 2017.http://apps.who.int/gho/data/view.main.57036ALL?lang=en
[33]
Parinitha S, Kulkarni M. Haematological changes in HIV infection with correlation to CD4 cell count. Australas Med J 2012; 5(3): 157-62.
[http://dx.doi.org/10.4066/AMJ.2012.100] [PMID: 22952560]
[34]
Ricci D, Ponzoni M, Zoldan MC, Germagnoli L, Faravarelli A. Bone marrow biopsy in 50 AIDS patients: a diagnostic approach. Pathologica 1995; 87(6): 640-5.
[PMID: 8927423]
[35]
Møller T, Hasselbalch HC. Hematological changes associated with human immunodeficiency virus (HIV-1) infection Ugeskr Laeger 1993; 155(19): 1442-6.
[PMID: 8316970]
[36]
Di Lorenzo G, Konstantinopoulos PA, Pantanowitz L, Di Trolio R, De Placido S, Dezube BJ. Management of AIDS-related Kaposi’s sarcoma. Lancet Oncol 2007; 8(2): 167-76.
[http://dx.doi.org/10.1016/S1470-2045(07)70036-0] [PMID: 17267331]
[37]
Hoffmann C, Sabranski M, Esser S. HIV-associated Kaposi’s sarcoma. Oncol Res Treat 2017; 40(3): 94-8.
[http://dx.doi.org/10.1159/000455971] [PMID: 28259888]
[38]
Letang E, Almeida JM, Miró JM, et al. Predictors of immune reconstitution inflammatory syndrome-associated with kaposi sarcoma in mozambique: a prospective study. J Acquir Immune Defic Syndr 2010; 53(5): 589-97.
[http://dx.doi.org/10.1097/QAI.0b013e3181bc476f] [PMID: 19801945]
[39]
Volkow P, Cesarman-Maus G, Garciadiego-Fossas P, Rojas-Marin E, Cornejo-Juárez P. Clinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcoma. AIDS Res Ther 2017; 14(1): 30.
[http://dx.doi.org/10.1186/s12981-017-0156-9] [PMID: 28558783]
[40]
Lebbe C, Garbe C, Stratigos AJ, et al. European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organisation for Research and Treatment of Cancer (EORTC). Diagnosis and treatment of Kaposi’s sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC). Eur J Cancer 2019; 114: 117-27.
[http://dx.doi.org/10.1016/j.ejca.2018.12.036] [PMID: 31096150]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 18
ISSUE: 4
Year: 2020
Published on: 03 June, 2020
Page: [277 - 282]
Pages: 6
DOI: 10.2174/1570162X18666200603145640
Price: $65

Article Metrics

PDF: 30
HTML: 1